Sector Chart Oragenics, Inc.

Stocks

OGEN

US6840236094

Biotechnology & Medical Research

Market Closed - NYSE 16:10:00 2026-09-04 EDT			5-day change	1st Jan Change
0.5100 ^USD	+2.31%		-2.71%	-34.88%

08-13	Oragenics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-07	Oragenics Achieves Full Activation of Australian Phase IIa Trial Network for ONP-002 and Advances U.S. Regulatory Pathway	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes